STK11 alterations as predictive biomarkers of resistance to immune checkpoint inhibitors in multiple cancers with mismatch repair gene alterations

被引：0
|
作者：
Iglesia, Michael
Khushman, Moh'd M.
Lim, Kian-Huat
Van Tine, Brian Andrew
Liu, Jingxia
Pedersen, Katrina Sophia
Liu, Xiuli
Trikalinos, Nikolaos
Suresh, Rama
Aranha, Olivia
Grierson, Patrick
Tan, Benjamin R.
Govindan, Ramaswamy
机构：
[1] Washington Univ, Siteman Canc Ctr, Sch Med, St Louis, MO USA
[2] Washington Univ St Louis, Siteman Canc Ctr, St Louis, MO USA
[3] Washington Univ, Sch Med, St Louis, MO USA
[4] Washington Univ St Louis, St Louis, MO USA
[5] Washington Univ, St Louis, MO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2619
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A novel STK11 gene mutation (c.388dupG, p.Glu130Glyfs*33) in a Peutz-Jeghers family and evidence of higher gastric cancer susceptibility associated with alterations in STK11 region aa 107-170
    Forte, Giovanna
    Cariola, Filomena
    De Marco, Katia
    Manghisi, Andrea
    Guglielmi, Filomena Anna
    Armentano, Raffaele
    Lippolis, Giuseppe
    Giorgio, Pietro
    Simone, Cristiano
    Disciglio, Vittoria
    GENES & DISEASES, 2022, 9 (02) : 288 - 291
  • [42] Correlation of BRAF genomic alterations with higher mutation burden and predictive response to immune checkpoint inhibitors among human malignancies.
    Kuan, Feng-Che
    Shi, Chung-Sheng
    Lin, Meng-Hung
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [43] The differential response to immune checkpoint inhibitors (ICIs) according to mismatch repair alterations in gastrointestinal (GI) non-colorectal cancers (non-CRCs) and the impact of dual vs. monotherapy ICIs on survival in GI (CRC and non-CRC) cancers
    Khushman, Moh'd M.
    Wu, Sharon
    Xiu, Joanne
    Farrell, Alex Patrick
    Shields, Anthony F.
    Marshall, John
    Lenz, Heinz-Josef
    Hall, Michael J.
    Abraham, Jim
    Oberley, Matthew James
    Sledge, George W.
    Spetzler, David
    Sahin, Ibrahim Halil
    Iglesia, Michael
    Lou, Emil
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] Primary Resistance to Immune Checkpoint Blockade in an STK11/TP53/KRAS-Mutant Lung Adenocarcinoma with High PD-L1 Expression
    Kwack, Won Gun
    Shin, So Youn
    Lee, Seung Hyeun
    ONCOTARGETS AND THERAPY, 2020, 13 : 8901 - 8905
  • [45] Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status
    Cohen, Romain
    Hain, Elisabeth
    Buhard, Olivier
    Guilloux, Agathe
    Bardier, Armelle
    Kaci, Rachid
    Bertheau, Philippe
    Renaud, Florence
    Bibeau, Frederic
    Flejou, Jean-Francois
    Andre, Thierry
    Svrcek, Magali
    Duval, Alex
    JAMA ONCOLOGY, 2019, 5 (04) : 551 - 555
  • [46] Peripheral Blood Biomarkers Predictive of Efficacy Outcome and Immune-Related Adverse Events in Advanced Gastrointestinal Cancers Treated with Checkpoint Inhibitors
    Zhang, Zhening
    Xie, Tong
    Qi, Changsong
    Zhang, Xiaotian
    Shen, Lin
    Peng, Zhi
    CANCERS, 2022, 14 (15)
  • [47] A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancers
    Liu, Ying L.
    Weigelt, Britta
    CANCER, 2024, 130 (10) : 1733 - 1746
  • [48] STK11 Loss-of-Function Variants Mediate Immune Evasion in NSCLC via Dysregulation of the FAK/Hippo Signaling Axis and Subsequent Alterations in Tumor-Intrinsic Cytokine Expression
    Donnelly, L. L.
    Lenahan, S.
    Gao, C.
    Sarausky, H. M.
    Hogan, T. C.
    Deming, P.
    Seward, D. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1212 - 1212
  • [49] STK11/LKB1 revisited: A prognostic rather than predictive biomarker for immune checkpoint inhibitor in EGFR/ALKWT nonsquamous non-small cell lung cancer (NSCLC).
    Zhao, Hui
    Qi, Nan
    Chen, Dianjun
    Li, Donghui
    Fu, Yan
    Xu, Yu
    Wang, Guoqiang
    Bai, Yuezong
    Du, Nan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] Identification of Acetylation, Immune Cell Alterations and Gene Signature As Dynamic Biomarkers of Response to Panobinostat Treatment in Multiple Myeloma Patients
    Mithraprabhu, Sridurga
    Savvidou, Ioanna
    Ramachandran, Malarmathy
    Kalff, Anna
    Khong, Tiffany T.
    Reed, Kate
    Reynolds, John
    Spencer, Andrew
    BLOOD, 2017, 130
12345